Brainstorm Cell Therapeutics Inc.
BCLINASDAQ
Healthcare
Biotechnology
$0.82
-0.02(-2.4%)
52W $0.48 – $1.36
Quick:
10-K
Mar 31, 2026 (6 days ago)Annual Report
Full-year financial statements and risk factors
YoY revenue/margin trends, new risk disclosures
8-K
Mar 31, 2026 (6 days ago)Current Report
Material event disclosure
Event materiality and market reaction
8-K
Feb 27, 2026 (1 months ago)Current Report
Material event disclosure
Event materiality and market reaction
8-K
Feb 13, 2026 (1 months ago)Current Report
Material event disclosure
Event materiality and market reaction
8-K
Jan 9, 2026 (2 months ago)Current Report
Material event disclosure
Event materiality and market reaction
8-K
Nov 14, 2025 (4 months ago)Current Report
Material event disclosure
Event materiality and market reaction
10-Q
Nov 14, 2025 (4 months ago)Quarterly Report
Quarterly financial update
Sequential growth, guidance changes
8-K
Nov 6, 2025 (5 months ago)Current Report
Material event disclosure
Event materiality and market reaction
10-Q
Aug 14, 2025 (7 months ago)Quarterly Report
Quarterly financial update
Sequential growth, guidance changes
8-K
Aug 14, 2025 (7 months ago)Current Report
Material event disclosure
Event materiality and market reaction
8-K
Jul 17, 2025 (8 months ago)Current Report
Material event disclosure
Event materiality and market reaction
8-K
Jun 25, 2025 (9 months ago)Current Report
Material event disclosure
Event materiality and market reaction
8-K
Jun 16, 2025 (9 months ago)Current Report
Material event disclosure
Event materiality and market reaction
SCHEDULE 13G
May 15, 2025 (10 months ago)Beneficial Ownership
Large shareholder position disclosure
Ownership threshold, passive vs active
10-Q
May 15, 2025 (10 months ago)Quarterly Report
Quarterly financial update
Sequential growth, guidance changes
8-K
May 15, 2025 (10 months ago)Current Report
Material event disclosure
Event materiality and market reaction
8-K
Apr 21, 2025 (11 months ago)Current Report
Material event disclosure
Event materiality and market reaction
8-K
Mar 31, 2025 (1 years ago)Current Report
Material event disclosure
Event materiality and market reaction
10-K
Mar 31, 2025 (1 years ago)Annual Report
Full-year financial statements and risk factors
YoY revenue/margin trends, new risk disclosures
8-K
Mar 31, 2025 (1 years ago)Current Report
Material event disclosure
Event materiality and market reaction